Vida Ventures, LLC bought KYTX
February 12, 2024 · Form 4 insider transaction
Vida Ventures, LLC bought 583 shares of Kyverna Therapeutics, Inc. at $22.00 per share, a transaction worth $12.8K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
583
Price
$22.00
Total value
$12.8K
InsiderVida Ventures, LLC
Role10% owner
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateFebruary 12, 2024
Filing dateFebruary 14, 2024
Shares owned after583
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
The shares of the Issuer's Common Stock are held directly by Vida Ventures III-A, L.P. ("Vida III-A"). Vida III GP is the general partner of Vida III-A. Vida III GP disclaims beneficial ownership of the securities held by Vida III-A, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their pecuniary interest therein, if any.